Pay in 4 interest-free payments of $6.47 Learn more
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5
People who begin obesity treatment with glucagon-like peptide-1 receptor agonists (GLP-1s) and then undergo metabolic and bariatric surgery achieve substantially greater weight loss than with the medications alone, according to new research presented today at the annual meeting of the American Society for Metabolic and Bariatric Surgery (#ASMBS2026)
6-Month Results: Improved confidence, better appetite control, and more energy
doi: 10.1371/journal.pntd.0011607
Jonathann Kuo, MD Tirzepatide gives us two levers instead of one
Am J Gastroenterol 119(6):11261140 Rotondo A, Janssen P, Mul F, Tack J (2013) Effect of the GLP-1 analog liraglutide on satiation and gastric sensorimotor function during nutrient-drink ingestion
US$ 25.83
US$ 20.46
US$ 22.57
US$ 29.82
US$ 29.06
US$ 25.18
